BREAKING: Attorneys for some 2,000 local governments say they have tentative agreement to settle opioid cases with Purdue Pharma.
FILE - In this August 2018 file photo, family and friends who have lost loved ones to OxyContin and opioid overdoses protest outside Purdue Pharma headquarters in Stamford, Conn. OxyContin maker Purdue Pharma made headlines when it reached a landmark settlement with Oklahoma over the toll the opioids crisis has taken on that state. Attempts to do the same in a major federal case in Ohio are proving more difficult.
HARTFORD, Conn. — Attorneys representing some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation’s opioid crisis. Attorney Paul Farrell says in a text message Wednesday that they have agreed to a deal in which Stamford, Connecticut-based Purdue would pay up to $12 billion and have the Sackler family, which owns the company, give up control.
The offer is the same as one publicly reported several weeks ago. It was not clear whether the announcement signaled the end of the fraught negotiations to reach a nationwide settlement with Purdue or moved the talks into a new phase.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Exclusive: Purdue Pharma nears partial opioid settlement, bankruptcy filing - sourcesOxyContin maker Purdue Pharma LP is nearing a partial agreement to resolve wides...
Consulte Mais informação »
Purdue Pharma Settles Lawsuit Over Its Role In Opioid Crisis: ReportsPurdue Pharma has reportedly settled a consolidated federal lawsuit made up of more than 2,000 cities and counties accusing the OxyContin maker of being responsible for the country’s sweeping opioid crisis
Consulte Mais informação »
Opioid talks break down; Purdue owners balk at paying $4.5 billionSettlement talks between Purdue Pharma and the states and cities suing the opioid maker stall after state officials ask for $4.5B instead of a discussed guarantee of $3B
Consulte Mais informação »
Can a Fashion Line With Roots in the Opioid Crisis Ever Find Success Without Controversy?Elizabeth Kennedy, the designer tapped to work on Joss Sackler's LBV line, says the duo are trying to create 'something new and fresh' — but they can't escape its founder's ties to OxyContin.
Consulte Mais informação »